Skip to main content

Table 1 Clinical characteristics and lipid analyses of the study population.

From: The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion

Trait Controls (n = 161) Cases (n = 212) p-value
Age 46.8 ± 19.57 (161) 53.2 ± 12.08 (211) <0.001
Gender(%female) 49.1 (161) 41.5 (212) < 0.09
TC 183.9 ± 36.66 (161) 293.9 ± 72.83 (212) *
TG 100.0 ± 37.81 (161) 376.7 ± 347.98 (212) *
VLDL-C 11.1 ± 7.77 (133) 69.0 ± 57.90 (212) *
VLDL-TG 47.7 ± 30.08 (133) 275.8 ± 256.25 (212) <0.001
LDL-C 122.1 ± 31.08 (133) 180.5 ± 55.96 (211) *
LDL-TG 29.9 ± 12.15 (133) 75.2 ± 177.92 (211) <0.001
HDL-C 52.9 ± 14.18 (158) 40.6 ± 12.48 (212) <0.001
HDL-TG 15.5 ± 4.88 (158) 21.7 ± 9.68 (212) <0.001
TG/HDL-C 1.97 ± 1.42 (158) 11.46 ± 17.59 (212) 0.211
BMI 25.3 ± 4.08 (93) 27.7 ± 4.54 (154) <0.001
  1. With the exception of gender, means and standard deviations are reported. * Use of these variables as a case selection criterion precludes report of a statistic.
  2. TC, total cholesterol; TG, triglyceride; VLDL-C, very low density lipoprotein – cholesterol; LDL-C, low density lipoprotein-cholesterol; HDL, high density lipoprotein; BMI, body mass index.